Please login to the form below
Treatment Investigational New Drug (IND)
A regulation in the US which attempts to give seriously ill patients access to new developmental drugs as early as possible. These drugs are generally made available during phase III studies before general marketing begins.
COVID-19 Updates and Daily News
Featured jobs
- SAD/ Group Account Director, Medical Communications, Remote UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Medical Writer, MRNA/ Covid 19, Medical Communications, U...
-
Highly competitive salary
- UK trial of fourth vaccine dose shows increased protection against COVID-19
- Biogen and MedRhythms sign deal worth over $120m for digital therapeutics for MS patients
- EIT Health and Biogen announce winners of first ‘neurotechprize’
- Biogen and Eisai announce FDA submission for early Alzheimer’s treatment
- Roche reinforces commitment to the World Federation of Hemophilia Humanitarian Aid Program
- FDA limits use of Janssen’s COVID-19 vaccine
- Shionogi and F2G partner to develop antifungal treatment olorofim
- Viseven and Next Pharma Partnership Announcement
- Holistic Excellence
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
- Scientists discover new approach to treat brain tumours
- SOLVE FSHD announces the appointment of Dr Eva Chin as its executive director
- Biogen retracts EMA application for Alzheimer's drug Aduhelm
- BioXcel Therapeutics begins phase 3 trial for acute agitation in Alzheimer’s patients
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
- Roche shares new positive Ocrevus data for MS patients
- WHO releases estimates of 14.9 million excess deaths during COVID-19 pandemic
- Patient journey mapping: exploring the clinical and the emotional journey
PMHub
Graphite Digital
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...
